<DOC>
	<DOCNO>NCT00171769</DOCNO>
	<brief_summary>This trial design provide data feasibility safety short-term treatment low-molecular-weight heparin certoparin patient persistent nonvalvular atrial fibrillation</brief_summary>
	<brief_title>Atrial Fibrillation Feasibility Certoparin Trial - AFFECT</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Certoparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>persistent AF ( electrical cardioversion plan ) write informed consent acute clinical sign venous thromboembolism current oral anticoagulation indication medical cardioversion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>